Peter Svennilson, 10% Owner, Director, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 128,626 shares at $17.89 ($2.3M) on 2020-08-13, disclosed to the SEC on 2020-08-17.
Open-market purchase of $2.3M NGM by 10% Owner, Director, Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.89 | 19,895 | $356K | 15.7% |
| 2 | $17.89 | 19,895 | $356K | 15.7% |
| 3 | $17.49 | 37,993 | $664K | 29.3% |
| 4 | $17.49 | 37,993 | $664K | 29.3% |
| 5 | $17.89 | 6,425 | $115K | 5.1% |
| 6 | $17.89 | 6,425 |
| $115K |
| 5.1% |
| Total | $17.65 avg | 128,626 | $2.3M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |